钙化防御一例

Received:2017-06-14 Revised:2017-11-24 Online:2018-08-15 Published:2018-07-31

［1］	Harris RJ, Cropley TG. Possible role of hypercoagulability in calciphylaxis: review of the literature［J］. J Am Acad Dermatol, 2011,64（2）:405⁃412.<br />
［2］	Davis JM. The relationship between obesity and calciphylaxis: a review of the literature［J］. Ostomy Wound Manage, 2016,62（1）:12⁃18.<br />
［3］	Hayashi M. Calciphylaxis: diagnosis and clinical features［J］. Clin Exp Nephrol, 2013,17（4）:498⁃503.<br />
［4］	Nigwekar SU1, Wolf M, Sterns RH, et al. Calciphylaxis from nonu⁃remic causes: a systematic review［J］. Clin J Am Soc Nephrol, 2008,3（4）:1139⁃1143.<br />
［5］	Halasz CL, Munger DP, Frimmer H, et al. Calciphylaxis: com⁃parison of radiologic imaging and histopathology［J］. J Am Acad Dermatol, 2017,77（2）:241⁃246.e3. doi: 10.1016/j.jaad.2017.01.040.<br />
［6］	Raymond CB, Wazny LD, Sood AR. Sodium thiosulfate, bispho⁃sphonates, and cinacalcet for calciphylaxis［J］. CANNT J, 2009,19（4）:25⁃27.<br />
［7］	Isoherranen K, Bouchard L, Kluger N. Benefits of intralesional injections of sodium thiosulfate in the treatment of calciphylaxis［J］. Int Wound J, 2017,14（6）:955⁃959. doi: 10.1111/iwj.12738.<br />

PDF